查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1420993

凝血酶市场（产品：牛凝血酶、人类凝血酶和重组凝血酶；剂型：粉末形式、溶液形式等）- 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Thrombin Market (Product: Bovine Thrombin, Human Thrombin, and Recombinant Thrombin; and Dosage Form: Powder Form, Solution Form, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 162 Pages | 商品交期: 2-10个工作天内

价格

凝血酶市场 - 报告范围

TMR 关于全球凝血酶市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了该期间全球凝血酶市场的收入2017-2031年，以2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球凝血酶市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解凝血酶市场。

市场概况
2023年市场价值 6.522 亿美元
2031 年市场价值 11 亿美元
CAGR 6.1%

该报告深入探讨了全球凝血酶市场的竞争格局。全球凝血酶市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球凝血酶市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2023-2031 年全球市场分析与预测

第 5 章：关键见解

  • 目前的趋势
  • 技术进步
  • COVID-19 影响分析

第 6 章：全球市场分析与预测：依产品分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按产品，2023-2031
    • 牛科
    • 人类
    • 重组
  • 市场吸引力分析：按产品

第 7 章：全球市场分析与预测：按剂型

  • 简介与定义
  • 主要发现/进展
  • 市值预测：按剂型，2023-2031
    • 粉状
    • 解决方案形式
    • 其他的
  • 市场吸引力分析：按剂型

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2023-2031
    • 医院
    • 诊断中心和诊所
    • 学术及研究机构
  • 市场吸引力分析：按最终用户

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Johnson & Johnson
    • Pfizer, Inc.
    • Mallinckrodt Pharmaceuticals
    • Mochida Pharmaceutical Co., Ltd.
    • BIOFAC A/S
    • Biomed-Lublin SA
    • Hualan Biological Engineering, Inc.
Product Code: TMRGL19580

Thrombin Market - Scope of Report

TMR's report on the global thrombin market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global thrombin market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global thrombin market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the thrombin market.

Market Snapshot
Market Value in 2023US$ 652.2 Mn
Market Value in 2031US$ 1.1 Bn
CAGR6.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global thrombin market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global thrombin market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global thrombin market.

The report delves into the competitive landscape of the global thrombin market. Key players operating in the global thrombin market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global thrombin market profiled in this report.

Key Questions Answered in Global thrombin Market Report:

  • What is the sales/revenue generated by thrombin across all regions during the forecast period?
  • What are the opportunities in the global thrombin market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Thrombin Market - Research Objectives and Research Approach

The comprehensive report on the global thrombin market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global thrombin market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global thrombin market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Thrombin Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Thrombin Market Analysis and Forecasts, 2023-2031

5. Key Insights

  • 5.1. Current Trends in Thrombin
  • 5.2. Technological advancements in Thrombin
  • 5.3. COVID-19 Impact Analysis

6. Global Thrombin Market Analysis and Forecasts, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2023-2031
    • 6.3.1. Bovine Thrombin
    • 6.3.2. Human Thrombin
    • 6.3.3. Recombinant Thrombin
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Thrombin Market Analysis and Forecasts, by Dosage Form

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Dosage Form, 2023-2031
    • 7.3.1. Powder Form
    • 7.3.2. Solution Form
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Dosage Form

8. Global Thrombin Market Analysis and Forecasts, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2023-2031
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Centers & Clinics
    • 8.3.3. Academic & Research Institutes
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Thrombin Market Analysis and Forecasts, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Thrombin Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2023-2031
    • 10.2.1. Bovine Thrombin
    • 10.2.2. Human Thrombin
    • 10.2.3. Recombinant Thrombin
  • 10.3. Market Value Forecast, by Dosage Form, 2023-2031
    • 10.3.1. Powder Form
    • 10.3.2. Solution Form
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by End-user, 2023-2031
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostic Centers & Clinics
    • 10.4.3. Academic & Research Institutes
  • 10.5. Market Value Forecast, by Country, 2023-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Dosage Form
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Thrombin Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2023-2031
    • 11.2.1. Bovine Thrombin
    • 11.2.2. Human Thrombin
    • 11.2.3. Recombinant Thrombin
  • 11.3. Market Value Forecast, by Dosage Form, 2023-2031
    • 11.3.1. Powder Form
    • 11.3.2. Solution Form
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by End-user, 2023-2031
    • 11.4.1. Hospitals
    • 11.4.2. Diagnostic Centers & Clinics
    • 11.4.3. Academic & Research Institutes
  • 11.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Dosage Form
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Thrombin Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2023-2031
    • 12.2.1. Bovine Thrombin
    • 12.2.2. Human Thrombin
    • 12.2.3. Recombinant Thrombin
  • 12.3. Market Value Forecast, by Dosage Form, 2023-2031
    • 12.3.1. Powder Form
    • 12.3.2. Solution Form
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by End-user, 2023-2031
    • 12.4.1. Hospitals
    • 12.4.2. Diagnostic Centers & Clinics
    • 12.4.3. Academic & Research Institutes
  • 12.5. 12.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Dosage Form
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Thrombin Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2023-2031
    • 13.2.1. Bovine Thrombin
    • 13.2.2. Human Thrombin
    • 13.2.3. Recombinant Thrombin
  • 13.3. Market Value Forecast, by Dosage Form, 2023-2031
    • 13.3.1. Powder Form
    • 13.3.2. Solution Form
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by End-user, 2023-2031
    • 13.4.1. Hospitals
    • 13.4.2. Diagnostic Centers & Clinics
    • 13.4.3. Academic & Research Institutes
  • 13.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Dosage Form
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Thrombin Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2023-2031
    • 14.2.1. Bovine Thrombin
    • 14.2.2. Human Thrombin
    • 14.2.3. Recombinant Thrombin
  • 14.3. Market Value Forecast, by Dosage Form, 2023-2031
    • 14.3.1. Powder Form
    • 14.3.2. Solution Form
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by End-user, 2023-2031
    • 14.4.1. Hospitals
    • 14.4.2. Diagnostic Centers & Clinics
    • 14.4.3. Academic & Research Institutes
  • 14.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Dosage Form
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Johnson & Johnson
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Strategic Overview
      • 15.3.1.5. SWOT Analysis
    • 15.3.2. Pfizer, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Strategic Overview
      • 15.3.2.5. SWOT Analysis
    • 15.3.3. Mallinckrodt Pharmaceuticals
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Strategic Overview
      • 15.3.3.5. SWOT Analysis
    • 15.3.4. Shanghai RAAS Blood Products Co., Ltd.
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Strategic Overview
      • 15.3.4.5. SWOT Analysis
    • 15.3.5. Japan Blood Products Organization
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Strategic Overview
      • 15.3.5.5. SWOT Analysis
    • 15.3.6. Mochida Pharmaceutical Co., Ltd.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Strategic Overview
      • 15.3.6.5. SWOT Analysis
    • 15.3.7. BIOFAC A/S
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Strategic Overview
      • 15.3.7.5. SWOT Analysis
    • 15.3.8. Biomed-Lublin S.A.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Strategic Overview
      • 15.3.8.5. SWOT Analysis
    • 15.3.9. Hualan Biological Engineering, Inc.
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Strategic Overview
      • 15.3.9.5. SWOT Analysis

List of Tables

  • Table 01: Global Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 02: Global Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
  • Table 03: Global Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 04: Global Thrombin Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 05: North America Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 06: North America Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
  • Table 07: North America Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 08: North America Thrombin Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 09: Europe Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 10: Europe Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
  • Table 11: Europe Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 12: Europe Thrombin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 13: Asia Pacific Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 14: Asia Pacific Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
  • Table 15: Asia Pacific Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 16: Asia Pacific Thrombin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 17: Latin America Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 18: Latin America Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
  • Table 19: Latin America Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 20: Latin America Thrombin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 21: Middle East & Africa Thrombin Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 22: Middle East & Africa Thrombin Market Value (US$ Mn) Forecast, by Dosage Form, 2023-2031
  • Table 23: Middle East & Africa Thrombin Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 24: Middle East & Africa Thrombin Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

List of Figures

  • Figure 01: Global Thrombin Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 02: Global Thrombin Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 03: Global Thrombin Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 04: Global Thrombin Market Value Share Analysis, by Dosage Form 2022 and 2031
  • Figure 05: Global Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 06: Global Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 07: Global Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 08: Global Thrombin Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 09: Global Thrombin Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 10: North America Thrombin Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 11: North America Thrombin Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 12: North America Thrombin Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 13: North America Thrombin Market Value Share Analysis, by Dosage Form, 2022 and 2031
  • Figure 14: North America Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 15: North America Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 16: North America Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 17: North America Thrombin Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 18: North America Thrombin Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 19: Europe Thrombin Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 20: Europe Thrombin Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 21: Europe Thrombin Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 22: Europe Thrombin Market Value Share Analysis, by Dosage Form, 2022 and 2031
  • Figure 23: Europe Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 24: Europe Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 25: Europe Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 26: Europe Thrombin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 27: Europe Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 28: Asia Pacific Thrombin Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 29: Asia Pacific Thrombin Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 30: Asia Pacific Thrombin Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 31: Asia Pacific Thrombin Market Value Share Analysis, by Dosage Form 2022 and 2031
  • Figure 32: Asia Pacific Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 33: Asia Pacific Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 34: Asia Pacific Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 35: Asia Pacific Thrombin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Asia Pacific Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 37: Latin America Thrombin Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 38: Latin America Thrombin Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 39: Latin America Thrombin Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 40: Latin America Thrombin Market Value Share Analysis, by Dosage Form, 2022 and 2031
  • Figure 41: Latin America Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 42: Latin America Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 43: Latin America Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 44: Latin America Thrombin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 45: Latin America Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Middle East & Africa Thrombin Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 47: Middle East & Africa Thrombin Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 48: Middle East & Africa Thrombin Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 49: Middle East & Africa Thrombin Market Value Share Analysis, by Dosage Form, 2022 and 2031
  • Figure 50: Middle East & Africa Thrombin Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 51: Middle East & Africa Thrombin Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 52: Middle East & Africa Thrombin Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 53: Middle East & Africa Thrombin Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 54: Middle East & Africa Thrombin Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 55: Global Thrombin Market Share Analysis, by Company, 2022